news
Researchers reveal IgHV3-53 is the most common immunoglobulin mutation used…
14 July 2020 | By Hannah Balfour (Drug Target Review)
Researchers reveal IgHV3-53 is the most common immunoglobulin mutation used to target the receptor binding domain on the SARS-CoV-2 spike protein.